US EditionPublished • loading... • Updated
AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence
WILMINGTON, DE — AstraZeneca plc (Nasdaq: AZN) is sharply expanding its ambitions in hematology and cell therapy, unveiling new clinical data across blood cancers as it makes its largest-ever showing at the American Society of Hematology annual meeting. The drugmaker said it will present 65 abstracts at the Dec. 6–9 conference, spanning eight approved and investigational medicines, including 15 oral presentations. The scale of the presence refle…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
